Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.25 $4.30 Thursday, 9th May 2024 GERN stock ended at $3.88. This is 1.84% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 3.16% from a day low at $3.80 to a day high of $3.92.
90 days $1.64 $4.30
52 weeks $1.64 $4.30

Historical Geron Corporation prices

Date Open High Low Close Volume
Jul 06, 2016 $2.64 $2.73 $2.62 $2.68 1 420 800
Jul 05, 2016 $2.75 $2.77 $2.65 $2.67 1 390 400
Jul 01, 2016 $2.66 $2.76 $2.65 $2.75 1 562 200
Jun 30, 2016 $2.62 $2.73 $2.62 $2.68 1 643 600
Jun 29, 2016 $2.68 $2.70 $2.60 $2.64 2 326 700
Jun 28, 2016 $2.49 $2.65 $2.48 $2.64 2 594 100
Jun 27, 2016 $2.55 $2.60 $2.42 $2.42 2 396 600
Jun 24, 2016 $2.63 $2.69 $2.56 $2.59 2 444 500
Jun 23, 2016 $2.69 $2.75 $2.67 $2.75 1 116 800
Jun 22, 2016 $2.68 $2.78 $2.62 $2.67 1 357 100
Jun 21, 2016 $2.78 $2.82 $2.64 $2.68 1 975 000
Jun 20, 2016 $2.76 $2.86 $2.74 $2.80 2 411 500
Jun 17, 2016 $2.72 $2.80 $2.71 $2.73 4 496 600
Jun 16, 2016 $2.66 $2.71 $2.60 $2.70 1 432 399
Jun 15, 2016 $2.70 $2.76 $2.66 $2.69 1 209 437
Jun 14, 2016 $2.71 $2.75 $2.63 $2.69 2 150 808
Jun 13, 2016 $2.75 $2.78 $2.69 $2.71 1 885 521
Jun 10, 2016 $2.78 $2.81 $2.73 $2.77 1 667 647
Jun 09, 2016 $2.92 $2.93 $2.81 $2.81 1 668 956
Jun 08, 2016 $2.99 $3.02 $2.93 $2.95 1 473 651
Jun 07, 2016 $3.09 $3.09 $2.97 $2.98 1 450 036
Jun 06, 2016 $2.97 $3.14 $2.91 $3.12 2 254 274
Jun 03, 2016 $3.07 $3.09 $2.96 $2.96 1 878 408
Jun 02, 2016 $2.97 $3.08 $2.97 $3.07 1 636 767
Jun 01, 2016 $2.95 $3.04 $2.92 $2.98 1 537 107
Click to get the best stock tips daily for free!

About Geron Corporation

Geron Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes a... GERN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT